Baylor College of Medicine: Compound D16 Reduces Tumor Growth and Overcomes Therapeutic Resistance in Mutant P53-Bearing Cancers
September 28, 2023
September 28, 2023
HOUSTON, Texas, Sept. 28 (TNSres) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine have developed a new compound called d16 that can reduce tumor growth and overcome therapeutic resistance in mutant p53-bearing cancers in the lab. The findings, published in the journal Cancer Research Communications, a journal of the American Association for Cancer Research, open opportunities for new combination therapies for these difficult-to- . . .
Researchers at Baylor College of Medicine have developed a new compound called d16 that can reduce tumor growth and overcome therapeutic resistance in mutant p53-bearing cancers in the lab. The findings, published in the journal Cancer Research Communications, a journal of the American Association for Cancer Research, open opportunities for new combination therapies for these difficult-to- . . .